# Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite

> **NCT00311051** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Research Center Borstel**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ramatroban
- **DRUG:** montelukast

## Key facts

- **NCT ID:** NCT00311051
- **Lead sponsor:** Research Center Borstel
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311051, "Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00311051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*